Gene Editing Cell Line

Gene Editing Cell Line Overview

Since the emergence of CRISPR gene editing technology in 2012, it has become the preferred choice of scientists worldwide due to its simplicity, specificity, and high efficiency. In 2020, researchers working on the CRISPR system were awarded the Nobel Prize in Chemistry. CRISPR gene editing technology has been utilized to explore biological functions, analyze gene information, and provide strategic support for humanity in the fight against diseases and in the design of crops. It also enables the development of gene-edited animal cell lines for studying gene function, disease mechanisms, and potential therapeutic targets. It has also facilitated the development of advanced research models, including engineered cell systems such as the HEK293-ERBB2 cell line, which are used to investigate gene function, signaling pathways, and therapeutic targets. In recent years, CRISPR technology has also undergone a series of improvements, including reduced off-target effects, increased editing sites, and more efficient delivery methods, which will have a lasting and profound impact on scientific research, agriculture, and the medical field, particularly in applications such as cell line construction for advanced functional studies.

Kyinno offers more than 200 various CRISPR gene-editing cell lines, encompassing knockout and knockin cells, along with customized services for researchers, including custom gene-edited cell line construction. Our gene-edited cell lines can be employed in the exploration of protein or RNA biological functions, drug screening, synthetic lethal research, and numerous other applications. Representative models include antigen-modified tumor variants such as the CT26-GPC3 cell line, developed to support target validation and immuno-oncology research. Additionally, we can employ pegRNA and prime editing, as well as lipid nano-particle (LNP) technology, to perform multi-site editing simultaneously, enhancing gene editing efficiency while minimizing off-target effects.

Filter by Product Type
Filter by Category
Filter by Generation Method
Filter by Host
Total Results: 371

More Products Related to Gene Editing Cell Line

The fluorescent protein (GFP) gene was cloned, and the availability of fluorescent tags has significantly expanded. A major advantage of fluorescence-labeled cell lines is their non-toxic nature, making them suitable for use in living cells.
Tumors and their various products can reshape the tumor microenvironment (TME), suppressing immune cells within the TME. Kyinno offers a range of immune molecule cell lines, encompassing various immune molecules such as PD1, IL2RB, IL6 and more.
Since the emergence of CRISPR gene editing technology in 2012, it has become the preferred choice of scientists worldwide due to its simplicity, specificity, and high efficiency. In 2020, researchers working on the CRISPR system were awarded the Nobel Prize in Chemistry.
Reporter cell lines are extensively utilized in the study of gene expression regulation, signal transduction pathways, receptor-ligand interactions, and enable researchers to track intracellular signal transduction. They can be employed to monitor signal transduction induced by small molecules or cytokines,
Kinases play crucial roles in various complex cellular pathways, including cell metabolism, cell signaling, and cell transport, making them vital to human physiology. Kyinno offers more than 850 Ba/F3 or human kinase cell lines, encompassing various signaling pathways.
The resistance of tumor cells to chemotherapeutic drugs stands as one of the most critical factors contributing to the failure of tumor treatment, representing the foremost challenge in current tumor therapy.  Kyinno’s drug-resistant cell models exhibit greater stability in resistance, making them easier to maintain in culture for ongoing research projects.
Kyinno offers a range of tumor antigen cell lines covering various signaling pathways, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), erb-b2 receptor tyrosine kinase 2 (ERBB2), HLA, GPRC5D, ROR1, CLDN18.2, GPC3, Siglec15, DLL3, LAG3, B7H3, B7H4, B7H6, FAP, and more.